Clinical implication of pulmonary fibrosis genetics

Pulmonary and Critical Care Grand Rounds

When

1 to 3 p.m., Oct. 31, 2023

Where

Arizona Health Sciences Building, Room 8403, 1501 N. Campbell Ave., Tucson, AZ 85724

Join virtually

Presenter

Chad A. Newton, MD

Assistant professor of Internal Medicine, associate director of ILD Program

UT Southwestern Medical Center

Chad Newton is an assistant professor in the Department of Internal Medicine at the UT Southwestern Medical Center and serves as the associate director of the UTSW Interstitial Lung Disease Program. He obtained his undergraduate degree from the University of North Texas. After college, he attended the University of Texas Southwestern Medical School, where he completed residency in Internal Medicine and fellowship in Pulmonary & Critical Care Medicine. Newton is an NIH-funded investigator whose research is focused on understanding the complex genetic and molecular mechanisms that predispose to pulmonary fibrosis and inform clinical course once disease is established. Through this effort, he has characterized the clinical outcomes of patients with telomere-related pulmonary fibrosis and demonstrated the potential utility of leukocyte telomere length as prognostic biomarker.

Learning objectives

  • Understand the importance of family history ascertainment for pulmonary fibrosis patients.
  • Recognize differences in management of familial and sporadic pulmonary fibrosis patients.  
  • Understand how genetic information can inform pulmonary fibrosis management decisions.  

This is not a CME earning lecture.